Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study Finds Rapid Heroin Detoxification Procedure Under Anesthesia Does Not Work and Can Result in Death

25.08.2005


Columbia University Medical Center and New York State Psychiatric Institute Researchers


Illustrate Severe Risk in Popular Procedure, Identify Safer Procedure

An increasingly common method of heroin detoxification under general anesthesia is ineffective and unsafe, according to a study by psychiatrists at Columbia University Medical Center and the New York State Psychiatric Institute at Columbia.

The study, published in the August 24 Journal of the American Medical Association (JAMA), is the first rigorously controlled trial to monitor all of the critical outcomes associated with the procedure, including comfort, treatment retention, abstinence rates and the ability to receive the full and effective dose of naltrexone, a drug that blocks activation on the receptor sites in the brain where the opioids attach.



Heroin addiction is notoriously difficult to overcome. The nervous system of heroin users adapts over time to accommodate to chronic exposure to the opioid, and its sudden absence during detoxification results in excruciating withdrawal symptoms, including nausea, diarrhea, abdominal pain, insomnia and irritability. Despite improvements in recent decades, medically supervised heroin withdrawal remains plagued by patient discomfort and high dropout rates. This has led to the growth of ultra-rapid, anesthesia-assisted opioid withdrawal procedures, which have been publicized as a fast, painless way to withdraw from opioids.

Results of the JAMA study, however, found that the procedure can lead to risk of death, psychosis and increased stress. Other studies have found other risks including delirium, attempted suicide, abnormal heart rhythm and acute renal failure. The anesthesia method is also prohibitively expensive, with most centers charging between $5,000 and $15,000 for the procedure.

“Our research illustrated that rapid heroin detoxification under anesthesia does not work well enough to justify the significant risk and expense,” said Eric D. Collins, M.D., assistant professor of clinical psychiatry at Columbia University Medical Center and the New York State Psychiatric Institute, and the project director and first author on the study.

The study compared detoxification under anesthesia to two other alternative methods. Detoxification with a single dose of the drug buprenorphine was slower than anesthesia, but more effective and significantly less expensive. The third option, using the drug clonidine, was the slowest method and the least effective.

“Quitting heroin use can be an extremely painful process and we continue to strive to identify more comfortable and rapid methods of helping patients reach that goal,” said Herbert D. Kleber, M.D., professor of psychiatry at Columbia University Medical Center, director of the substance abuse division at the New York State Psychiatric Institute and principal investigator on the study. “Unfortunately the anesthesia method is not the answer.”

Dr. Kleber believes that regardless of the detoxification method used, the treatment received after detoxification is the most important factor in determining the ultimate success in remaining off heroin, as Patrick G. O’Connor, M.D., of the Yale University School of Medicine argued in his accompanying JAMA editorial.

Most of the approximately one million heroin-dependent Americans are not in treatment, and their main initial contact with the treatments system is often detoxification. Throughout the 20th century, many methods of opioid detoxification have been proposed – including insulin-induced seizures, artificial hibernation and electroconvulsive therapy. But these approaches often produced greater morbidity and mortality than untreated withdrawal.

Craig LeMoult | EurekAlert!
Further information:
http://www.cumc.columbia.edu
http://www.nyspi.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>